CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint

Data Compilation
#PharmaFlow

Pipeline Prospector June 2025: Sanofi, AbbVie, Eli Lilly, BioNTech lead pharma M&A spree; BMS, Astra ink major collaborations

Stock Recap
#PipelineProspector

Bisoprolol Fumarate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

57 API Suppliers, 15 USDMF, 19 CEP/COS, 8 JDMF, 11 EU WC, 5 KDMF, 11 NDC API, 40 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

767 FDF Dossiers, 69 FDA Orange Book, 421 Europe, 22 Canada, 48 Australia, 62 South Africa, 145 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 5 DKSH, 2 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 5 Actylis, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 16 BASF, 1 Clariant, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Esteem Industries, 1 Finar, 10 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 14 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 13 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives, 42 Fillers, Diluents & Binders, 27 Direct Compression, 20 Thickeners and Stabilizers, 20 Controlled & Modified Release, 19 Granulation, 17 Disintegrants & Superdisintegrants, 17 Solubilizers, 14 Topical, 13 Lubricants & Glidants, 13 Film Formers & Plasticizers, 11 Co-Processed Excipients, 10 Taste Masking, 7 Emulsifying Agents, 7 Rheology Modifiers, 7 Chewable & Orodispersible Aids, 6 Parenteral, 5 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Coloring Agents

DIGITAL CONTENT

19 News #PharmaBuzz

19 News #PharmaBuzz

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 350 Regulatory FDF Prices, 3 Annual Reports

MARKET PLACE

30 APIs, 22 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 14 Others

ANALYTICAL

4 BioAnalytical Methods

4 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
28/06/2025	Moehs Iberica	Spain	MOEHS IBERICA S. L.	218MF10893	Bisoprolol fumarate	2006-11-10	2019-09-11	Cesar Martinell i Brunet 12A, Poligono Rubi Sur, Rubi (Barcelona), Spain
28/06/2025	Sichuan Qingmu Pharmaceutical	China	Chengdu Easton Biopharmaceuticals Co. , Ltd.	230MF10053	Bisoprolol fumarate	2018-04-17	2018-04-17	No. 8, Xiyuan Avenue, Hi-Tech District, Chengdu, 611731, China.

Bisoprolol Fumarate

Bisoprolol Fumarate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

57 API Suppliers

15 USDMF

19 CEP/COS

8 JDMF

11 EU WC

5 KDMF

11 NDC API

40 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

767 FDF Dossiers

69 FDA Orange Book

421 Europe

22 Canada

48 Australia

62 South Africa

145 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma

5 DKSH

2 Boai NKY Pharmaceuticals Ltd

4 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 ACG Worldwide

5 Actylis

1 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

16 BASF

1 Clariant

10 Corel Pharma Chem

4 DFE Pharma

1 Esteem Industries

1 Finar

10 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

4 Ideal Cures

3 Ingredion Pharma Solutions

14 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

10 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

1 Pharmatrans-Sanaq

4 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

16 Roquette

13 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

3 Silverline Chemicals

2 The Dow Chemical Company

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives

42 Fillers, Diluents & Binders

27 Direct Compression

20 Thickeners and Stabilizers

20 Controlled & Modified Release

19 Granulation

17 Disintegrants & Superdisintegrants

TABLET;ORAL - 10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons